HLA-DP control of human Schistosoma haematobium infection.

The DPA1 and DPB1 alleles of the major histocompatibility complex (MHC) class II were determined in 110 patients and 120 healthy controls of a Gabonese population from an area endemic for Schistosoma haematobium infection. The MHC-DP alleles of the variable second exons and their human leukocyte antigen (HLA) epitopes were correlated with egg excretion, interleukin-4 and interferon-gamma patterns, and bladder abnormalities, as detected by ultrasonography. A methionine at position 11 of the DP alpha molecule (Met-11) and DPA1*0301 were associated with schistosomiasis when compared with controls (phenotypic gene frequencies = 0.791 versus 0.583 and 0.555 versus 0.375, respectively). Met-11 homozygosity occurred more often in patients, whereas healthy controls were more frequently homozygous for an alanine at position 11 (Ala-11). The combination of the DPB1-epitope DEAV (positions 84-87 of the DP beta molecule) and Met-11 positive DPA1 alleles was more frequent in patients than in controls (0.573 versus 0.316). Two years after antischistosomal treatment, the rate of reinfection as examined in 55 of the 110 former patients was higher in DPA1*0301-positive individuals than in those not possessing this allele (P < 0.001). Ala-11 positive individuals showed less frequently ultrasonographic signs of bladder pathology than Ala-11 negative individuals (P < 0.05). Our results suggest a role of MHC-DP elements in the manifestation of disease in S. haematobium infection.

[1]  A. Mahmoud,et al.  Association of HLA class I antigens (A1, B5, B8 and CW2) with disease manifestations and infection in human schistosomiasis mansoni in Egypt. , 2008, Tissue antigens.

[2]  C. Meyer,et al.  HLA-DP--part of the concert. , 1997, Immunology today.

[3]  P. Kremsner,et al.  DPA1*0105, a novel DPA1 variant in a negroid population. , 1996, Tissue Antigens.

[4]  W. Secor,et al.  Association of hepatosplenic schistosomiasis with HLA-DQB1*0201. , 1996, The Journal of infectious diseases.

[5]  J. Weissenbach,et al.  Genetic localization of a locus controlling the intensity of infection by Schistosoma mansoni on chromosome 5q31–q33 , 1996, Nature Genetics.

[6]  P. Kremsner,et al.  Elevated proliferation and interleukin‐4 release from CD4+ cells after chemotherapy in human Schistosoma haematobium infection , 1996, European journal of immunology.

[7]  B. Mordmüller,et al.  Antischistosome IgG4 and IgE responses are affected differentially by chemotherapy in children versus adults. , 1996, The Journal of infectious diseases.

[8]  A. Begovich,et al.  HLA-D alleles associated with generalized disease, localized disease, and putative immunity in Onchocerca volvulus infection. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[9]  D. Wiley,et al.  Three-dimensional structure of the human class II histocompatibility antigen HLA-DR1 , 1993, Nature.

[10]  A. Capron,et al.  Immunity after treatment of human schistosomiasis: association between IgE antibodies to adult worm antigens and resistance to reinfection , 1992, European journal of immunology.

[11]  L. Abel,et al.  Evidence for the segregation of a major gene in human susceptibility/resistance to infection by Schistosoma mansoni. , 1991, American journal of human genetics.

[12]  A. Simpson,et al.  Human IgE, IgG4 and resistance to reinfection with Schistosomahaematobium , 1991, Nature.

[13]  M. Bassett,et al.  Relationship between bladder cancer incidence, Schistosoma haematobium infection, and geographical region in Zimbabwe. , 1990, Transactions of the Royal Society of Tropical Medicine and Hygiene.

[14]  B. Sellin,et al.  Ultrasonographic assessment of urinary tract lesions due to Schistosoma haematobium in Niger after four consecutive years of treatment with praziquantel. , 1990, Tropical medicine and parasitology : official organ of Deutsche Tropenmedizinische Gesellschaft and of Deutsche Gesellschaft fur Technische Zusammenarbeit.

[15]  J. Caulfield,et al.  How does the schistosome evade host defenses? , 1990, Gastroenterology.

[16]  N. Ohta,et al.  HLA‐DQ‐controlled T cell response to soluble egg antigen of Schistosoina japonicuin in huinans , 1990, Clinical and experimental immunology.

[17]  S. Carding,et al.  MHC control of CD4+ T cell subset activation , 1989, The Journal of experimental medicine.

[18]  T. Sasazuki,et al.  HLA-DQ is epistatic to HLA-DR in controlling the immune response to schistosomal antigen in humans , 1987, Nature.

[19]  A. Elwi,et al.  A quantitative post mortem analysis of urinary schistosomiasis in Egypt. I. Pathology and pathogenesis. , 1974, The American journal of tropical medicine and hygiene.

[20]  B. Haldane.  THE ESTIMATION AND SIGNIFICANCE OF THE LOGARITHM OF A RATIO OF FREQUENCIES , 1956, Annals of human genetics.

[21]  J. May,et al.  Met-11 of HLA class II DP alpha 1 first domain associated with onchocerciasis. , 1996, Experimental and clinical immunogenetics.

[22]  P. Kremsner,et al.  DPB1*BR: an Mhc class II DPB1 allele (DPB1*6601) of negroid origin , 1996, Immunogenetics.

[23]  J. Klein,et al.  The molecular descent of the major histocompatibility complex. , 1993, Annual review of immunology.

[24]  P. Hagan.  Reinfection, exposure and immunity in human schistosomiasis. , 1992, Parasitology today.

[25]  A. Kimura.  Eleventh international histocompatibility workshop reference protocol for the HLA DNA-typing technique , 1992 .

[26]  H. Krieger,et al.  On the association between HLA-A1 and B5 and clinical forms of schistosomiasis mansoni. , 1991, Memorias do Instituto Oswaldo Cruz.

[27]  R. Sturrock,et al.  Immunology of schistosomiasis. , 1990 .

[28]  Z. Shaker,et al.  Association between HLA-A, B, C and DR antigens and clinical manifestations of Schistosoma haematobium in the bladder. , 1989, European urology.

[29]  T. Sasazuki,et al.  Immunogenetic analysis of patients with post-schistosomal liver cirrhosis in man. , 1982, Clinical and experimental immunology.